Pharmacological and clinical effects of medical cannabis
- Cannabis contains many medicinal substances.
- Here is an overview of those whose effect has been confirmed in the past and today they alleviate pain in some diseases.
Content
Cannabis or marijuana has been used for medical purposes for years. There are several types of cannabinoid medicines available in the United States and Canada . Dronabinol (Scheme III), nabilone (Scheme II) and nabiximols (not approved by the US Food and Drug Administration) are drugs made from marijuana. Medical cannabis or medical marijuana, a deciduous plant cultivated for the production of leaves and flowering heads, is grown for these purposes, but patients also obtain them through free cannabis dispensing points or through national programs.
Effects of individual substances
The effects of cannabinoid compounds on cannabinoid receptors (CB1 and CB2) found in the brain can elicit different pharmacological responses based on the characteristics and characteristics of the patient. Cannabinoid Δ9-tetrahydrocannabinol has been found to have primary psychoactive effects; the effects of several other key cannabinoid compounds have not yet been fully elucidated.
Dronabinol and nabilone are indicated for the treatment of nausea and vomiting associated with cancer chemotherapy and anorexia associated with weight loss in patients with acquired immune deficiency syndrome.
However, pain and muscle cramps are the most common reasons why medical cannabis is recommended. Medical cannabis studies show significant improvements in various types of muscle pain and spasticity. The side effects reported are usually not serious, with dizziness being the most common.
Concerns about safety in cannabis use include an increased risk of developing schizophrenia, memory and cognition impairment, accidental cannabis consumption by a child, and a lack of safety packaging for cannabis in the form of medicines.
Sources: study , image: www.herb.co